1. Home
  2. CMCT vs RLMD Comparison

CMCT vs RLMD Comparison

Compare CMCT & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMCT
  • RLMD
  • Stock Information
  • Founded
  • CMCT 1993
  • RLMD 2004
  • Country
  • CMCT United States
  • RLMD United States
  • Employees
  • CMCT N/A
  • RLMD N/A
  • Industry
  • CMCT Real Estate Investment Trusts
  • RLMD Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMCT Real Estate
  • RLMD Health Care
  • Exchange
  • CMCT Nasdaq
  • RLMD Nasdaq
  • Market Cap
  • CMCT 12.9M
  • RLMD 11.5M
  • IPO Year
  • CMCT N/A
  • RLMD N/A
  • Fundamental
  • Price
  • CMCT $0.75
  • RLMD $0.37
  • Analyst Decision
  • CMCT
  • RLMD Hold
  • Analyst Count
  • CMCT 0
  • RLMD 4
  • Target Price
  • CMCT N/A
  • RLMD $4.25
  • AVG Volume (30 Days)
  • CMCT 1.3M
  • RLMD 942.1K
  • Earning Date
  • CMCT 11-08-2024
  • RLMD 03-18-2025
  • Dividend Yield
  • CMCT 22.38%
  • RLMD N/A
  • EPS Growth
  • CMCT N/A
  • RLMD N/A
  • EPS
  • CMCT N/A
  • RLMD N/A
  • Revenue
  • CMCT $124,599,000.00
  • RLMD N/A
  • Revenue This Year
  • CMCT N/A
  • RLMD N/A
  • Revenue Next Year
  • CMCT N/A
  • RLMD N/A
  • P/E Ratio
  • CMCT N/A
  • RLMD N/A
  • Revenue Growth
  • CMCT 6.77
  • RLMD N/A
  • 52 Week Low
  • CMCT $0.11
  • RLMD $0.34
  • 52 Week High
  • CMCT $4.40
  • RLMD $7.22
  • Technical
  • Relative Strength Index (RSI)
  • CMCT 54.56
  • RLMD 25.62
  • Support Level
  • CMCT $0.91
  • RLMD $0.36
  • Resistance Level
  • CMCT $1.06
  • RLMD $0.49
  • Average True Range (ATR)
  • CMCT 0.18
  • RLMD 0.06
  • MACD
  • CMCT 0.01
  • RLMD 0.08
  • Stochastic Oscillator
  • CMCT 33.83
  • RLMD 10.06

About CMCT Creative Media & Community Trust Corporation

Creative Media & Community Trust is formed to invest in, own, and operate Class A and creative office investments in improving urban communities throughout the United States. It operates through segments such as office, hotel and multifamily properties and lending. The Office segment includes rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment relates to operations of hotel properties whereas, the lending segment refers to income from the yield and other related fee income earned on its loans receivable. The lending segment includes income recognized from the sale of government guaranteed portion of loans receivable, income from the yield on its loans receivable and other related fee income earned.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: